| |||||||||||||||||||||
|
|||||||
![]() |
|
|
LinkBack | Thread Tools | Display Modes |
|
||||
|
Biofuel catalyst maker Codexis abandons $100 million IPO, citing market conditions
In New York, biocatalyst developer Codexis, which numbers Chevron, Bio*One Capital and Pfizer among its investors, cancelled a $100 million IPO, citing “unfavorable market conditions”. The company manufacturers catalysts for the biofuels and biotech industries. Shell had invested in the company last November to explore catalysts for biofuels.Shell purchases stake in Codexis, an enzyme manufacturer [...]
More... |
| Sponsored links |
![]() |
| Thread Tools | |
| Display Modes | |
|
|